Clearmind Medicine Inc.

NASDAQ: CMND · Real-Time Price · USD
1.03
0.01 (0.98%)
At close: Aug 15, 2025, 3:59 PM
1.03
0.00%
After-hours: Aug 15, 2025, 07:10 PM EDT

Clearmind Medicine Income Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a 11.51K 15.19K n/a n/a 3.96K 17.91K 10.57K 18.7K 35.86K 60.16K 5.22K 12.14K 2.57K n/a n/a n/a
Gross Profit
n/a n/a -11.51K -15.19K n/a n/a -3.96K -17.91K -10.58K -18.7K -35.86K -60.16K -5.22K -12.14K -2.57K n/a n/a n/a
Operating Income
-1.31M -1.5M -1.59M -1.47M -1.7M -1.54M 474.6K -1.2M -1.22M -1.84M -1.57M -1.84M -3.03M -2.08M -2.31M -1.08M -188.82K -98.61K
Interest Income
41.65K 34.01K 91.67K 85.02K 33.95K 60.58K 17.64K 17.3K 5.97K 18.02K n/a 6.6K n/a n/a n/a n/a n/a n/a
Pretax Income
-763.27K -1.03M -787.62K -2.05M -871.46K -1.17M -2.95M -435.79K -1.52M -1.84M -2.08M -2.02M -3.17M -2.09M -2.53M -1.08M -188.82K -98.61K
Net Income
-783.93K -1.07M -884.74K -2.09M -908.22K -1.37M -2.96M -430.82K -1.53M -1.84M -2.62M -2.19M -3.46M -2.09M -2.53M -1.08M -188.82K -98.61K
Selling & General & Admin
855.12K 1.03M 1.09M 1.13M 980.55K 1.16M 943.66K 628.36K 984.4K 1.26M 988.64K 1.4M 1.44M 1.65M 1.72M 1.03M 188.82K 98.61K
Research & Development
451.86K 461.44K 483.73K 343.12K 322.96K 227.48K 272.45K 197.7K 233.57K 593.52K 532.07K 444.03K 1.58M 424.26K 589.23K 57.26K n/a n/a
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 35.85K 60.16K 5.22K 12.14K n/a n/a n/a n/a
Operating Expenses
1.31M 1.5M 1.57M 1.46M 1.3M 1.38M 1.24M 826.06K 1.22M 1.85M 1.56M 1.9M 3.03M 2.09M 2.31M 1.08M 188.82K 98.61K
Interest Expense
7.87K 8.71K 36.16K n/a n/a n/a 6K -7.94 n/a n/a 4.49K 15.19K 143.51K 10.46K 223.22K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.31M 1.5M -1.59M 1.47M 1.3M 1.38M 1.24M 826.06K 1.22M 1.85M 1.56M 1.9M 3.03M 2.09M 2.31M 1.08M 188.82K 98.61K
Income Tax Expense
20.66K 39.34K 97.12K 42.59K 36.76K 201.5K 8.25K -4.97K 6.82K 3.42K 543.4K 165.17K 287.03K 8.93K 223.22K -54K -55.8K -55.21K
Shares Outstanding (Basic)
5.04M 4.49M 4.27M 3.56M 3.25M 1.52M 3.56M 2.36M 1.25M 765.91K 439.92K 439.91K 436.37K 417.26K 420K 350K 210K 210K
Shares Outstanding (Diluted)
5.04M 4.49M 4.27M 3.56M 3.25M 1.52M 3.56M 2.36M 1.25M 765.91K 439.92K 439.91K 436.37K 417.26K 426.23K 355.79K 214.28K 213.61K
EPS (Basic)
-0.16 -0.24 -0.21 -0.59 -0.28 -0.9 -11.44 -2.43 -16.62 -23.82 -36.24 -35.76 -57.42 -39.56 -48.25 -24.75 -7 -3.59
EPS (Diluted)
-0.16 -0.24 -0.21 -0.59 -0.28 -0.9 -11.44 -2.43 -16.62 -23.82 -36.24 -35.76 -57.42 -39.56 -48.25 -24.75 -7 -3.59
EBITDA
-1.3M -1.01M -1.18M -1.46M -1.69M -1.53M -1.09M -1.08M -1.64M -1.81M -1.56M -1.78M -2.88M -2.07M -2.31M -1.08M -188.82K -98.61K
EBIT
-1.31M -1.02M -1.19M -1.47M -1.3M -1.38M -1.09M -1.1M -1.66M -1.83M -1.26M -1.04M -1.72M -1.63M -1.87M -867.7K -153.8K -77.14K
Depreciation & Amortization
11.97K 12.04K 11.51K 15.19K 15.74K 8.63K 3.96K 17.91K 10.57K 18.7K 35.86K 60.16K 5.22K 12.14K 2.57K 54K 55.81K 55.21K